Quotient Sciences completes major investments, expansions in Nottingham, UK
The new clinical pharmacology space and expanded development laboratories increase the company’s capacity to conduct integrated Translational Pharmaceutics programmes for global pharma and biotech customers
Quotient Sciences | 26/09/2022 | By Sudeep Soparkar | 489
The full integration of drug substance R&D and manufacturing follows a year after the company's acquisition of its Alnwick, UK site and provides a more streamlined approach from candidate selection through to commercialization. Quotient Sciences Translational Pharmaceutics approach combining manufacturing and clinical dosing at a single organization
Quotient Sciences | 18/02/2022 | By Darshana | 494
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy